5YJ1
Mouse Cereblon thalidomide binding domain complexed with R-form thalidomide
Experimental procedure
Experimental method | SINGLE WAVELENGTH |
Source type | SYNCHROTRON |
Source details | SPRING-8 BEAMLINE BL44XU |
Synchrotron site | SPring-8 |
Beamline | BL44XU |
Temperature [K] | 100 |
Detector technology | CCD |
Collection date | 2011-04-15 |
Detector | RAYONIX MX-225 |
Wavelength(s) | 0.9 |
Spacegroup name | H 3 |
Unit cell lengths | 201.615, 201.615, 123.572 |
Unit cell angles | 90.00, 90.00, 120.00 |
Refinement procedure
Resolution | 19.780 - 2.000 |
R-factor | 0.20025 |
Rwork | 0.199 |
R-free | 0.22766 |
Structure solution method | MOLECULAR REPLACEMENT |
Starting model (for MR) | 3wx2 |
RMSD bond length | 0.006 |
RMSD bond angle | 1.258 |
Data reduction software | HKL-2000 |
Data scaling software | HKL-2000 |
Phasing software | PHASER |
Refinement software | REFMAC (5.8.0049) |
Data quality characteristics
Overall | Outer shell | |
Low resolution limit [Å] | 50.000 | 2.050 |
High resolution limit [Å] | 2.000 | 1.980 |
Rmerge | 0.078 | 0.493 |
Number of reflections | 130317 | 12954 |
<I/σ(I)> | 20.6 | 3.9 |
Completeness [%] | 99.9 | 99.9 |
Redundancy | 5.8 | 5.6 |
Crystallization Conditions
crystal ID | method | pH | temperature | details |
1 | VAPOR DIFFUSION, SITTING DROP | 277 | 1.0M ammonium sulfate 0.1M sodium acetate (pH5.0) |